🇮🇱 Omnipaque 180 in Israel

Omnipaque 180 (IOHEXOL) regulatory status in Israel.

Marketing authorisation

MOH

  • Status: likely_approved

Omnipaque 180 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in Israel

Frequently asked questions

Is Omnipaque 180 approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Omnipaque 180 in Israel?

GE HealthCare is the originator. The local marketing authorisation holder may differ — check the official source linked above.